Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Herpes simplex (HSV) stromal keratitis is an infectious ocular disease of either necrotizing or non-necrotizing form, due to an HSV infection, and characterized by corneal stromal necrosis, inflammation, ulceration and infiltration by leukocytes. Corneal perforation and blindness can also occur in severe cases.
Biomarker and diagnostic research for stromal keratitis has been reported in the published literature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and gene therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily industry-sponsored.
54 publications have been identified in PubMed for stromal keratitis. Research spans Review / Meta-Analysis (28%), Basic Science / Preclinical (26%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 15 | 28% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
14 |
26% |
Patient case studies | 9 | 17% |
Disease patterns and progression | 6 | 11% |
Clinical study results | 5 | 9% |
Testing and diagnosis research | 2 | 4% |
New treatment approaches | 2 | 4% |
Other research | 1 | 2% |
Tiwari V (2026). [PMID: 41594640](https://pubmed.ncbi.nlm.nih.gov/41594640/). *Biomolecules*. [Review / Meta-Analysis]
Singh P (2026). [PMID: 34662065](https://pubmed.ncbi.nlm.nih.gov/34662065/). *Unknown Journal*. [Review / Meta-Analysis]
Gu W (2026). [PMID: 41754410](https://pubmed.ncbi.nlm.nih.gov/41754410/). *Pathogens*. [Review / Meta-Analysis]
Chen AC (2026). [PMID: 41915916](https://pubmed.ncbi.nlm.nih.gov/41915916/). *Cornea*. [Case Report / Case Series]
Rogers CM (2026). [PMID: 41795906](https://pubmed.ncbi.nlm.nih.gov/41795906/). *Equine Vet J*. [Basic Science / Preclinical]
Ahmad B (2026). [PMID: 31424862](https://pubmed.ncbi.nlm.nih.gov/31424862/). *Unknown Journal*. [Review / Meta-Analysis]
Minor M (2026). [PMID: 32491711](https://pubmed.ncbi.nlm.nih.gov/32491711/). *Unknown Journal*. [Review / Meta-Analysis]
Broekema NM (2026). [PMID: 41631754](https://pubmed.ncbi.nlm.nih.gov/41631754/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Sun Z (2026). [PMID: 42072341](https://pubmed.ncbi.nlm.nih.gov/42072341/). *Biomedicines*. [Basic Science / Preclinical]
Lotfy NM (2026). [PMID: 41784713](https://pubmed.ncbi.nlm.nih.gov/41784713/). *J Ophthalmic Inflamm Infect*. [Clinical Trial Publication]